Global life sciences company with a mission to
detect cancer early taps the cloud with the most functionality to
power breakthroughs
Today, Amazon Web Services, Inc. (AWS), an Amazon.com company
(NASDAQ: AMZN), announced that GRAIL, Inc., a life sciences company
whose mission is to detect cancer early, when it can be cured, has
selected AWS as its cloud infrastructure provider. With more than a
billion dollars in funding and advised by a world-class set of
industry and cancer experts, GRAIL is combining high-intensity
genomic sequencing with the techniques of modern data science as it
seeks to transform the way cancer is diagnosed. GRAIL is running
one of the largest clinical research programs ever pursued in
genomic medicine, and AWS will enable GRAIL to ingest hundreds of
thousands of records and genomic datasets, securely and reliably
store them, and choose from a wide range of analytics and machine
learning services to develop early detection products and
demonstrate their clinical utility.
GRAIL is collaborating with leading community and academic
medical centers to conduct its studies, which will create
unprecedented amounts of data as each patient record can contain as
much as a terabyte. By migrating its core processing and analytical
infrastructure from on-premises to AWS, GRAIL is leveraging AWS’s
unmatched breadth and depth of cloud functionality, HIPAA-compliant
services, and proven security to build a data science pipeline that
will allow GRAIL and its clinical partners to process and analyze
large-scale datasets.
“In today’s complex and competitive global healthcare
marketplace, technology is a cornerstone in our effort to develop
solutions that detect cancer at its earliest stages,” said Ken
Drazan, Chief Business Officer at GRAIL. “AWS’s cloud platform
provides critical infrastructure as we scale our databases and
computational tools to support our large population-scale clinical
studies and the development of our early detection products.”
“Customers across industries are using AWS’s comprehensive set
of storage, analytics, and machine learning services to power
massive-scale data analytics initiatives,” said Mike Clayville,
Vice President, Worldwide Commercial Sales at AWS. “GRAIL is
undertaking one of the largest, and most complex, data science
initiatives ever conceived. Running on the world’s most widely
adopted cloud platform will allow GRAIL to produce and analyze
datasets of unprecedented scale, securely collaborate with research
and clinical partners, and focus on developing the deepest and most
comprehensive understanding of cancer biology to reduce global
cancer mortality.”
GRAIL joins a growing list of life sciences and genomics
customers and partners running their cloud infrastructures on AWS,
including Novartis, Merck, AstraZeneca, GE, Cerner, Phillips, and
Bristol Meyers Squibb, along with academic institutions such as
NYU, Baylor and Harvard.
About Amazon Web Services
For 11 years, Amazon Web Services has been the world’s most
comprehensive and broadly adopted cloud platform. AWS offers over
90 fully featured services for compute, storage, networking,
database, analytics, application services, deployment, management,
developer, mobile, Internet of Things (IoT), Artificial
Intelligence (AI), security, hybrid, and enterprise applications,
from 43 Availability Zones (AZs) across 16 geographic regions in
the U.S., Australia, Brazil, Canada, China, Germany, India,
Ireland, Japan, Korea, Singapore, and the UK. AWS services are
trusted by millions of active customers around the world --
including the fastest growing startups, largest enterprises, and
leading government agencies -- to power their infrastructure, make
them more agile, and lower costs. To learn more about AWS, visit
https://aws.amazon.com.
About Amazon
Amazon is guided by four principles: customer obsession rather
than competitor focus, passion for invention, commitment to
operational excellence, and long-term thinking. Customer reviews,
1-Click shopping, personalized recommendations, Prime, Fulfillment
by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets,
Fire TV, Amazon Echo, and Alexa are some of the products and
services pioneered by Amazon. For more information, visit
www.amazon.com/about and follow @AmazonNews.
About GRAIL
GRAIL is a life sciences company whose mission is to detect
cancer early when it can be cured. GRAIL is using the power of
high-intensity sequencing, population-scale clinical trials, and
state of the art Computer Science and Data Science to enhance the
scientific understanding of cancer biology and develop blood tests
for early-stage cancer detection. The company’s funding was led by
ARCH Venture Partners and includes Amazon, Bezos Expeditions, Bill
Gates, Bristol-Myers Squibb, Celgene, Decheng Capital, GV,
Illumina, Johnson & Johnson Innovation, Merck, McKesson
Ventures, Sutter Hill Ventures, Tencent, Varian Medical Systems,
and other financial partners. For more information, please visit
www.grail.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170731005153/en/
Amazon.com, Inc.Media
HotlineAmazon-pr@amazon.comwww.amazon.com/pr
Amazon.com (NASDAQ:AMZN)
Historical Stock Chart
From Apr 2024 to May 2024
Amazon.com (NASDAQ:AMZN)
Historical Stock Chart
From May 2023 to May 2024